Model
Edge
Nabriva Therapeutics
0001732196
Filing Type
4
Filing Date
6/3/2021
Updated
6/4/21, 11:51 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership